Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Number of holders
-
159
-
Total 13F shares, excl. options
-
18,276,597
-
Shares change
-
-197,551
-
Total reported value, excl. options
-
$1,128,117,710
-
Value change
-
-$17,322,858
-
Put/Call ratio
-
2.73%
-
Number of buys
-
76
-
Number of sells
-
-82
-
Price
-
$61.39
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q1 2021
200 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q1 2021.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,276,597 shares
of 834,731,296 outstanding shares and own 2.19% of the company stock.
Largest 10 shareholders include ROYAL BANK OF CANADA (3,380,349 shares), RENAISSANCE TECHNOLOGIES LLC (2,037,138 shares), BlackRock Inc. (1,307,616 shares), VANGUARD GROUP INC (993,814 shares), STATE STREET CORP (902,000 shares), BANK OF MONTREAL /CAN/ (739,031 shares), MORGAN STANLEY (615,823 shares), DIMENSIONAL FUND ADVISORS LP (573,638 shares), NORTHERN TRUST CORP (421,026 shares), and GOLDMAN SACHS GROUP INC (395,464 shares).
This table shows the top 159 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.